Selective Membrane Protein Enrichment Enables Defined Biomimetic Nanoparticles for Endothelial Targeting

Area of Science:

• Biomaterials Science
• Nanotechnology
• Drug Delivery

Background:

• Biomimetic nanoparticles enhance drug delivery compatibility but lack defined protein compositions, hindering clinical use.
• Current approaches struggle with reproducibility and precise targeting for inflammation therapies.

Purpose of the Study:

• To develop a next-generation biomimetic nanoparticle (PNP) platform with defined membrane proteins for enhanced, tunable targeting.
• To engineer PNPs with leukocyte adhesion proteins for improved accumulation at inflamed sites.

Main Methods:

• Incorporated specific leukocyte adhesion proteins (CD18, CD11a, CD11b) into nanoparticle membranes.
• Utilized a 2D microfluidic model simulating human blood vessels to assess nanoparticle-endothelial interactions under flow.
• Compared adhesion-enriched PNPs against conventional Leukosomes for targeting efficiency.

Main Results:

• Adhesion-enriched PNPs showed significantly enhanced interactions with inflamed endothelium.
• PNPs demonstrated greater accumulation under flow conditions at inflamed sites compared to controls.
• The protein-defined platform offers improved targeting efficiency and reproducibility.

Conclusions:

• Protein-defined biomimetic nanoparticles (PNPs) represent a significant advancement for targeted inflammation therapies.
• This platform provides precise control and tunability for enhanced drug delivery and reduced toxicity.
• The developed PNPs show strong translational potential for clinical applications in treating inflammatory diseases.